Hoth Therapeutics Stock Buy Hold or Sell Recommendation
| HOTH Stock | USD 1.18 0.05 4.07% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Hoth Therapeutics is 'Sell'. Macroaxis provides Hoth Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HOTH positions. The advice algorithm takes into account all of Hoth Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Hoth Therapeutics' buy or sell advice are summarized below:
Real Value 2.18 | Target Price 5.25 | Hype Value 1.18 | Market Value 1.18 | Naive Value 1.06 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Hoth Therapeutics given historical horizon and risk tolerance towards Hoth Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Hoth Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Hoth |
Execute Hoth Therapeutics Buy or Sell Advice
The Hoth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hoth Therapeutics. Macroaxis does not own or have any residual interests in Hoth Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hoth Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Hoth Therapeutics Trading Alerts and Improvement Suggestions
| Hoth Therapeutics generated a negative expected return over the last 90 days | |
| Hoth Therapeutics may become a speculative penny stock | |
| Hoth Therapeutics has high historical volatility and very poor performance | |
| Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hoth Therapeutics currently holds about 11.62 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Hoth Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gizmodo.com: These Star Wars Toy Photos Are as Special as the Toys Themselves |
Hoth Therapeutics Returns Distribution Density
The distribution of Hoth Therapeutics' historical returns is an attempt to chart the uncertainty of Hoth Therapeutics' future price movements. The chart of the probability distribution of Hoth Therapeutics daily returns describes the distribution of returns around its average expected value. We use Hoth Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hoth Therapeutics returns is essential to provide solid investment advice for Hoth Therapeutics.
| Mean Return | -0.0052 | Value At Risk | -6.4 | Potential Upside | 8.94 | Standard Deviation | 4.72 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hoth Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Hoth Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Hoth Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Hoth Therapeutics backward and forwards among themselves. Hoth Therapeutics' institutional investor refers to the entity that pools money to purchase Hoth Therapeutics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Integrated Wealth Concepts Llc | 2023-09-30 | 0.0 | Citadel Advisors Llc | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-12-31 | 0.0 | Two Sigma Securities, Llc | 2023-12-31 | 0.0 | Vanguard Group Inc | 2023-12-31 | 38.8 K | Geode Capital Management, Llc | 2023-12-31 | 23.5 K | Ubs Group Ag | 2023-12-31 | 8.4 K | Jpmorgan Chase & Co | 2023-12-31 | 6.3 K | Tower Research Capital Llc | 2023-12-31 | 1.6 K | Royal Bank Of Canada | 2023-12-31 | 240 | Wells Fargo & Co | 2023-12-31 | 30.0 |
Hoth Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 1.6M | 738.8K | 5.9M | (2.1M) | 754.1K | 891.2K | |
| Depreciation | 1.2K | 1.2K | 1.0K | 124.0 | 111.6 | 106.02 | |
| Net Income | (7.7M) | (7.2M) | (14.3M) | (11.4M) | (7.8M) | (8.2M) | |
| End Period Cash Flow | 1.9M | 2.6M | 8.5M | 6.4M | 9.3M | 4.8M | |
| Change To Netincome | 143.1K | 2.5M | 1.2M | 1.7M | 1.5M | 1.2M | |
| Free Cash Flow | (5.0M) | (6.3M) | (12.2M) | (9.4M) | (8.4M) | (8.9M) | |
| Other Non Cash Items | 95K | 507.0K | 370.8K | 858.8K | (70.1K) | (66.6K) |
Hoth Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hoth Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hoth Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hoth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.08 | |
β | Beta against NYSE Composite | 1.08 | |
σ | Overall volatility | 4.70 | |
Ir | Information ratio | -0.02 |
Hoth Therapeutics Volatility Alert
Hoth Therapeutics exhibits very low volatility with skewness of 1.23 and kurtosis of 2.55. Hoth Therapeutics is a potential penny stock. Although Hoth Therapeutics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Hoth Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Hoth instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Hoth Therapeutics Fundamentals Vs Peers
Comparing Hoth Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hoth Therapeutics' direct or indirect competition across all of the common fundamentals between Hoth Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hoth Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Hoth Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Hoth Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hoth Therapeutics to competition |
| Fundamentals | Hoth Therapeutics | Peer Average |
| Return On Equity | -1.13 | -0.31 |
| Return On Asset | -0.59 | -0.14 |
| Current Valuation | (4.04 M) | 16.62 B |
| Shares Outstanding | 4.89 M | 571.82 M |
| Shares Owned By Insiders | 1.62 % | 10.09 % |
| Shares Owned By Institutions | 6.97 % | 39.21 % |
| Number Of Shares Shorted | 218.06 K | 4.71 M |
| Price To Earning | (7.16) X | 28.72 X |
| Price To Book | 0.68 X | 9.51 X |
| EBITDA | (7.69 M) | 3.9 B |
| Net Income | (7.85 M) | 570.98 M |
| Cash And Equivalents | 11.62 M | 2.7 B |
| Cash Per Share | 9.02 X | 5.01 X |
| Total Debt | 55.16 K | 5.32 B |
| Debt To Equity | 2.01 % | 48.70 % |
| Current Ratio | 15.74 X | 2.16 X |
| Book Value Per Share | 2.03 X | 1.93 K |
| Cash Flow From Operations | (8.45 M) | 971.22 M |
| Short Ratio | 0.19 X | 4.00 X |
| Earnings Per Share | (2.30) X | 3.12 X |
| Target Price | 4.67 | |
| Number Of Employees | 2 | 18.84 K |
| Beta | 0.61 | -0.15 |
| Market Capitalization | 5.77 M | 19.03 B |
| Total Asset | 9.52 M | 29.47 B |
| Retained Earnings | (52.94 M) | 9.33 B |
| Working Capital | 8.75 M | 1.48 B |
| Current Asset | 448.84 K | 9.34 B |
| Current Liabilities | 312.22 K | 7.9 B |
| Net Asset | 9.52 M |
Note: Acquisition by Robb Knie of 225000 shares of Hoth Therapeutics subject to Rule 16b-3 [view details]
Hoth Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hoth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hoth Therapeutics Buy or Sell Advice
When is the right time to buy or sell Hoth Therapeutics? Buying financial instruments such as Hoth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 506.8K | 692.7K | 614.2K | 352.1K | Total Assets | 11.0M | 6.8M | 9.5M | 5.8M |
Use Investing Ideas to Build Portfolios
In addition to having Hoth Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Hoth Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.